TY - JOUR T1 - Paediatric major incident triage and the use of machine learning techniques to develop an alternative triage tool with improved performance characteristics JF - medRxiv DO - 10.1101/2021.12.10.21267587 SP - 2021.12.10.21267587 AU - S. Chernbumroong AU - J. Vassallo AU - N.S. Malik AU - Y. Xu AU - D. Keene AU - MD. Lyttle AU - J.E. Smith AU - G.V. Gkoutos AU - in collaboration with PERUKI (Paediatric Emergency Research in the UK and Ireland) Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/12/19/2021.12.10.21267587.abstract N2 - Background Triage is a key principle in the effective management of major incidents. However, there is an increasing body of evidence demonstrating that existing paediatric methods are associated with high rates of under-triage and are not fit for purpose. The aim of this study was to derive a novel paediatric triage tool using machine learning (ML) techniques.Methods The United Kingdom Trauma Audit Research Network (TARN) database was interrogated for all paediatric patients aged under 16 years for the ten-year period 2008-2017. Patients were categorised as Priority One if they received one or more life-saving interventions from a previously defined list. Six ML algorithms were investigated for identifying patients as Priority One. Subsequently, the best performing model was chosen for further development using a risk score approach and clinically relevant modifications in order to derive a novel triage tool (LASSO M2).Using patients with complete pre-hospital physiological data, a comparative analysis was then performed comparing this to existing pre-hospital paediatric major incident triage tools. Performance was evaluated using sensitivity, specificity, under-triage (1-sensitivity) and over-triage (1-positive predictive value).Results Complete physiological data were available for 4962 patients. The LASSO M2 model demonstrated the best performance at identifying paediatric patients in need of life-saving intervention, sensitivity 88.8% (95% CI 85.5, 91.5) and was associated with the lowest rate of under-triage, 11.2% (8.5, 14.5). In contrast, the Paediatric Triage Tape and JumpSTART both had poor sensitivity when identifying those requiring life-saving intervention (36.1% (31.8, 40.7) and 44.7% (40.2, 49.4)) respectively.Conclusion The ML derived triage tool (LASSO M2) outperforms existing methods of paediatric major incident triage at identifying patients in need of life-saving intervention. Prior to its recommendation for clinical use, further work is required to externally validate its performance and undertake a feasibility assessment in a clinical context.What is known about this topic Children are frequently involved in all types of major incidents. A key principle in their management is triage, the process of prioritising patients on the basis of their clinical acuity.Unlike in the adult population, there are currently only a limited number of paediatric triage tools for use in a major incident, with a paucity of evidence supporting their use.A recent comparative analysis demonstrated that the adult triage tool, the MPTT-24, outperformed all existing pre-hospital paediatric triage tools at determining the Priority One paediatric patient.What this study adds We have applied machine learning algorithms to derive a novel triage tool, the LASSO M2.This triage tool demonstrated an absolute increase in sensitivity of 52ยท7% over the existing UK method of pre-hospital paediatric major incident triage, the Paediatric Triage Tape.This study has demonstrated that utilising additional parameters out with patient physiology, can lead to a marked improvement in triage tool performance.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study is funded by the National Institute for Health Research (NIHR) Surgical Reconstruction and Microbiology Research Centre. GVG also acknowledges support from the MRC Heath Data Research UK (HDRUK/CFC/01.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:TARN has ethical approval for research on anonymised patient data. This research is governed by the code of practice approved by the Confidentiality Advisory Group appointed by the NHS Health Research Authority. TARN has approval from the Confidentiality Advisory Group under Section 251 of the NHS Act 2006. Additional individual ethical approval was not required for this research.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDe-identified patient data utilised for this study are proprietary to the Trauma Audit and Research Network, University of Manchester and may be requested directly from TARN ER -